About Us

New Diagnostic Capabilities to Detect Lung Cancer Available

July 12, 2010

Lung Cancer is the leading cause of all cancer-related deaths in the United States among every ethnic group, taking more lives than breast, prostate, colon, liver, kidney, and melanoma cancers combined.1

Coliseum Medical Centers is now using the latest technology for diagnosing and staging lung cancer – the endobronchial ultrasound (EBUS) transbronchial needle aspiration (TBNA) system from Olympus. The EBUS-TBNA system is comprised of an innovative design, which features linear-scanning ultrasound imaging capability and a dedicated aspiration needle, specifically designed for diagnostic biopsies and staging in the lung. The EBUS scope offers real-time imaging and allows the physician to confirm the exact position of the needle in the lymph node. Unlike conventional transbronchial needle aspiration or mediastinoscopy, EBUS-TBNA’s breakthrough combination of maximum reliability and minimum invasiveness has made it the biopsy method of choice for more accurate diagnosis and staging in the lung. The needle itself has a specially designed “dimpled” tip, which enhances the view of the needle on the ultrasound image, making it easier to position for biopsy.

With these technical advancements offered by EBUS, many lymph nodes and lesions have become easier to sample, helping to increase the accuracy and reliability of bronchoscopy procedures.2
Unfortunately, only 16% of lung cancer is diagnosed at its earliest and most curable stage, and more than 51% of cases are diagnosed after the cancer has metastasized.1 With EBUS, it is now possible to diagnose lung cancer more accurately and for all lung cancer patients, using EBUS as a diagnostic tool provides several benefits. First, with EBUS, more lymph nodes are accessible compared to the conventional, more invasive surgical procedure, known as mediastinoscopy.2 Second, the patient avoids having to undergo a surgical procedure to obtain a diagnosis.2 Additionally, compared to surgery, the complication rate with EBUS is far lower and scheduling an outpatient procedure is easier to accomplish than scheduling operating room time.2

At the Coliseum Lung Health Center, physicians and staff work collaboratively to diagnose and treat patients with lung diseases and respiratory disorders, including, but not limited to, lung cancer, lung nodules, Mesothelioma and pulmonary fibrosis. An oncology nurse navigator works closely with the patients and their physicians to schedule all necessary diagnostic testing in order to expedite the rapid resolution of any abnormal findings. For more information about Coliseum Medical Centers’ services visit www.coliseumhealthsystem.com.

For more information about lung cancer, visit:

American Lung Association
Toll-free number: 1-800-586-4872
Web site: www.lungusa.org

Toll-free number: 1-800-813-HOPE
Web site: www.lungcancer.org

Lung Cancer Alliance
Toll-free number: 1-800-298-2436
Web site: www.lungcanceralliance.org

National Cancer Institute
Toll-free number: 1-800-4-CANCER
Web site: www.cancer.gov

About Olympus Medical Systems Group
Olympus, which incorporates surgical market leader Gyrus ACMI, develops solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy and early stage cancer evaluation and treatments, Olympus is transforming the future of healthcare.

About Olympus
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products.
Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products; 
  • Advanced clinical and research microscopes; 
  • Digital cameras and voice recorders.

Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results.  Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com.

1 Lung Cancer Alliance. “Lung Cancer Facts.” LungCancerAlliance.org. Accessed August 24, 2009 from  
2 Callaway Lane, Carol (RN, MSN ACNP-BC). “Endobronchial Ultrasound Guided Bronchoscopy: New Techniques in
   Daily Practice.” EndoNurse. December 2008.